A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Abroad (travel likely)RecruitingPHASE3
Conditions
Septic Shock · Sepsis · Hypovolemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Dignity Health Chandler Regional Medical Center, Chandler, Arizona, United States
Contact: Study coordinator (Kristopher Roach, MD)Memorial Health University Medical Center, Savannah, Georgia, United States
Contact: Study coordinator (Domenick Roma, MD)University Health, Kansas City, Missouri, United States
Contact: Study coordinator (Michael Moncure, MD)Bryan Medical Center, Lincoln, Nebraska, United States
Novant Healthcare, Winston-Salem, North Carolina, United States
Contact: Study coordinator (Daniel Feinstein, MD)Oregon Health & Science University (OHSU), Portland, Oregon, United States
Contact: Study coordinator (Akram Khan, MD)
Study leads
Cuthbert O Simpkins, MD, FACS
Principal Investigator
Vivacelle Bio